These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32397533)

  • 1. Morphometric, Hemodynamic, and Multi-Omics Analyses in Heart Failure Rats with Preserved Ejection Fraction.
    Zhang W; Zhang H; Yao W; Li L; Niu P; Huo Y; Tan W
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
    Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Canagliflozin can improve cardiac function in HFpEF rats partly by regulating ferroptosis].
    Ma S; Zuo QJ; He LL; Zhang GR; Zhai JL; Zhang TT; Wang ZL; Guo YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Sep; 52(9):1090-1100. PubMed ID: 39290000
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
    Klotz S; Hay I; Zhang G; Maurer M; Wang J; Burkhoff D
    Hypertension; 2006 May; 47(5):901-11. PubMed ID: 16585423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Arrhythmias Underlie Sudden Death in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Aynaszyan S; Holm K; Goldhaber JI; Marbán E; Cingolani E
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006452. PubMed ID: 30030266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological mechanism of heart failure with preserved ejection fraction in rats based on iTRAQ technology.
    Xu H; Gao K; Liu C; Li T; Ding Y; Ma J
    PeerJ; 2023; 11():e15280. PubMed ID: 37159835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
    Zhang T; Wang X; Wang Z; Zhai J; He L; Wang Y; Zuo Q; Ma S; Zhang G; Guo Y
    Pharmacology; 2023; 108(5):478-491. PubMed ID: 37611563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism.
    Kamimura D; Uchino K; Ishigami T; Hall ME; Umemura S
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):155-61. PubMed ID: 27046338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct features of calcium handling and β-adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction.
    Kilfoil PJ; Lotteau S; Zhang R; Yue X; Aynaszyan S; Solymani RE; Cingolani E; Marbán E; Goldhaber JI
    J Physiol; 2020 Nov; 598(22):5091-5108. PubMed ID: 32829489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
    Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics approach for identification of molecular alterations of QiShenYiQi dripping pills in heart failure with preserved ejection fraction.
    Huang Y; Zhang K; Wang X; Guo K; Li X; Chen F; Du R; Li S; Li L; Yang Z; Zhuo D; Wang B; Wang W; Hu Y; Jiang M; Fan G
    J Ethnopharmacol; 2023 Oct; 315():116673. PubMed ID: 37268257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse electrical remodeling in rats with heart failure and preserved ejection fraction.
    Cho JH; Kilfoil PJ; Zhang R; Solymani RE; Bresee C; Kang EM; Luther K; Rogers RG; de Couto G; Goldhaber JI; Marbán E; Cingolani E
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle.
    Bowen TS; Rolim NP; Fischer T; Baekkerud FH; Medeiros A; Werner S; Brønstad E; Rognmo O; Mangner N; Linke A; Schuler G; Silva GJ; Wisløff U; Adams V;
    Eur J Heart Fail; 2015 Mar; 17(3):263-72. PubMed ID: 25655080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-intensity interval training attenuates endothelial dysfunction in a Dahl salt-sensitive rat model of heart failure with preserved ejection fraction.
    Adams V; Alves M; Fischer T; Rolim N; Werner S; Schütt N; Bowen TS; Linke A; Schuler G; Wisloff U
    J Appl Physiol (1985); 2015 Sep; 119(6):745-52. PubMed ID: 26229002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan Reverses Cardiac Malfunction and Cardiomyocyte Ferroptosis During Heart Failure with Preserved Ejection Fraction via Connexin 43 Signaling Activation.
    Zhang LL; Chen GH; Tang RJ; Xiong YY; Pan Q; Jiang WY; Gong ZT; Chen C; Li XS; Yang YJ
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):705-718. PubMed ID: 36881213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Mátyás C; Németh BT; Oláh A; Török M; Ruppert M; Kellermayer D; Barta BA; Szabó G; Kökény G; Horváth EM; Bódi B; Papp Z; Merkely B; Radovits T
    Eur J Heart Fail; 2017 Mar; 19(3):326-336. PubMed ID: 27995696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon Receptor Antagonist for Heart Failure With Preserved Ejection Fraction.
    Gao C; Xiong Z; Liu Y; Wang M; Wang M; Liu T; Liu J; Ren S; Cao N; Yan H; Drucker DJ; Rau CD; Yokota T; Huang J; Wang Y
    Circ Res; 2024 Aug; 135(5):614-628. PubMed ID: 39011638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
    J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.